Christopher Pazdan's most recent trade in KORU Medical Systems Inc was a trade of 5,327 Common Stock done . Disclosure was reported to the exchange on May 14, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| KORU Medical Systems Inc | Christopher Pazdan | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 May 2026 | 5,327 | 310,458 (0%) | 0% | 0 | Common Stock | |
| KORU Medical Systems Inc | Christopher Pazdan | Chief Operating Officer | Purchase of securities on an exchange or from another person at price $ 3.88 per share. | 14 May 2026 | 5,000 | 305,131 (0%) | 0% | 3.9 | 19,400 | Common Stock |
| KORU Medical Systems Inc | Christopher Pazdan | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.94 per share. | 14 May 2026 | 1,470 | 308,988 (0%) | 0% | 3.9 | 5,792 | Common Stock |
| KORU Medical Systems Inc | Christopher Pazdan | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Mar 2026 | 46,929 | 46,929 | - | - | Option to buy Common Stock | |
| KORU Medical Systems Inc | Christopher Pazdan | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Mar 2026 | 31,226 | 31,226 | - | - | Restricted Stock Unit | |
| KORU Medical Systems Inc | Christopher Pazdan | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Mar 2026 | 31,226 | 31,226 | - | - | Performance Stock Unit | |
| KORU Medical Systems Inc | Christopher Pazdan | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Mar 2026 | 5,064 | 5,064 (0%) | 0% | 0 | Common Stock | |
| KORU Medical Systems Inc | Christopher Pazdan | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.28 per share. | 16 Mar 2026 | 1,628 | 3,436 (0%) | 0% | 4.3 | 6,968 | Common Stock |
| KORU Medical Systems Inc | Christopher Pazdan | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2025 | 36,077 | 36,077 | - | - | Option to buy Common Stock | |
| KORU Medical Systems Inc | Christopher Pazdan | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2025 | 21,308 | 21,308 | - | - | Restricted Stock Units | |
| KORU Medical Systems Inc | Christopher Pazdan | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2025 | 21,308 | 21,308 | - | - | Restricted Stock Units | |
| KORU Medical Systems Inc | Christopher Pazdan | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Mar 2025 | 36,331 | 84,474 (0%) | 0% | - | Common Stock | |
| KORU Medical Systems Inc | Christopher Pazdan | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Mar 2025 | 36,331 | 0 | - | - | Performance Share Unit | |
| KORU Medical Systems Inc | Christopher Pazdan | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.83 per share. | 17 Mar 2025 | 12,849 | 71,625 (0%) | 0% | 2.8 | 36,363 | Common Stock |
| KORU Medical Systems Inc | Christopher Pazdan | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Mar 2025 | 5,063 | 15,192 | - | - | Restricted Stock Units | |
| KORU Medical Systems Inc | Christopher Pazdan | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Mar 2025 | 5,063 | 49,784 (0%) | 0% | - | Common Stock | |
| KORU Medical Systems Inc | Christopher Pazdan | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.89 per share. | 17 Mar 2025 | 1,641 | 48,143 (0%) | 0% | 2.9 | 4,738 | Common Stock |
| KORU Medical Systems Inc | Christopher Pazdan | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2024 | 44,721 | 44,721 | - | - | Option to buy Common Stock | |
| KORU Medical Systems Inc | Christopher Pazdan | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2024 | 20,255 | 20,255 | - | - | Restricted Stock Units | |
| KORU Medical Systems Inc | Christopher Pazdan | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2024 | 20,255 | 20,255 | - | - | Restricted Stock Units |